These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8453945)

  • 1. Neuroprotective effect of felbamate after kainic acid-induced status epilepticus.
    Chronopoulos A; Stafstrom C; Thurber S; Hyde P; Mikati M; Holmes GL
    Epilepsia; 1993; 34(2):359-66. PubMed ID: 8453945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Felbamate in experimental model of status epilepticus.
    Mazarati AM; Baldwin RA; Sofia RD; Wasterain CG
    Epilepsia; 2000 Feb; 41(2):123-7. PubMed ID: 10691107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticonvulsant activity of felbamate in amygdala kindling model of temporal lobe epilepsy in rats.
    Wlaź P; Löscher W
    Epilepsia; 1997 Nov; 38(11):1167-72. PubMed ID: 9579916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of felbamate and other anticonvulsant drugs in two models of status epilepticus in the rat.
    Sofia RD; Gordon R; Gels M; Diamantis W
    Res Commun Chem Pathol Pharmacol; 1993 Mar; 79(3):335-41. PubMed ID: 8480078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isobolographic and subthreshold analysis of interactions among felbamate and four conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice.
    Borowicz KK; Luszczki JJ; Czuczwar SJ
    Epilepsia; 2004 Oct; 45(10):1176-83. PubMed ID: 15461671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic fibroblast growth factor is highly neuroprotective against seizure-induced long-term behavioural deficits.
    Liu Z; Holmes GL
    Neuroscience; 1997 Feb; 76(4):1129-38. PubMed ID: 9027873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of magnesium sulfate in kainic acid-induced status epilepticus.
    Mikati MA; Injibar H; Kurdi RM; El Hokayem J; Abou Rialy S; Lteif L; Abdul Jawad M; Francis E; Geha G; Farhat F
    J Med Liban; 2006; 54(4):200-4. PubMed ID: 17330372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levetiracetam and felbamate interact both pharmacodynamically and pharmacokinetically: an isobolographic analysis in the mouse maximal electroshock model.
    Luszczki JJ; Andres-Mach MM; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Epilepsia; 2007 Apr; 48(4):806-15. PubMed ID: 17284299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of valproate and phenobarbital treatment after status epilepticus in rats.
    Bolanos AR; Sarkisian M; Yang Y; Hori A; Helmers SL; Mikati M; Tandon P; Stafstrom CE; Holmes GL
    Neurology; 1998 Jul; 51(1):41-8. PubMed ID: 9674776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A neuropharmacological evaluation of felbamate as a novel anticonvulsant.
    White HS; Wolf HH; Swinyard EA; Skeen GA; Sofia RD
    Epilepsia; 1992; 33(3):564-72. PubMed ID: 1592038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Felbamate pharmacology and use in epilepsy.
    Burdette DE; Sackellares JC
    Clin Neuropharmacol; 1994 Oct; 17(5):389-402. PubMed ID: 9316688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of felbamate with several other antiepileptic drugs against seizures induced by maximal electroshock in mice.
    Gordon R; Gels M; Wichmann J; Diamantis W; Sofia RD
    Epilepsia; 1993; 34(2):367-71. PubMed ID: 8453946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of the EEG paroxysmal pattern during felbamate therapy in Lennox-Gastaut syndrome: a case report.
    Marciani MG; Spanedda F; Placidi F; Bassetti MA; Romigi A; Mattia D
    Int J Neurosci; 1998 Sep; 95(3-4):247-53. PubMed ID: 9777442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A self-complementary, self-assembling microsphere system: application for intravenous delivery of the antiepileptic and neuroprotectant compound felbamate.
    Lian H; Steiner SS; Sofia RD; Woodhead JH; Wolf HH; White HS; Shen GS; Rhodes CA; McCabe RT
    J Pharm Sci; 2000 Jul; 89(7):867-75. PubMed ID: 10861587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Felbamate in the treatment of Lennox-Gastaut syndrome: results of a 12-month open-label study following a randomized clinical trial.
    Dodson WE
    Epilepsia; 1993; 34 Suppl 7():S18-24. PubMed ID: 8243374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retigabine calms seizure-induced behavior following status epilepticus.
    Slomko AM; Naseer Z; Ali SS; Wongvravit JP; Friedman LK
    Epilepsy Behav; 2014 Aug; 37():123-32. PubMed ID: 25016241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of felbamate, kynurenic acid derivatives and NMDA antagonists on in vitro kainate-induced epileptiform activity.
    Domenici MR; Marinelli S; Sagratella S
    Life Sci; 1996 May; 58(26):PL391-6. PubMed ID: 8691980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Felbamate monotherapy has stimulant-like effects in patients with epilepsy.
    Ketter TA; Malow BA; Flamini R; Ko D; White SR; Post RM; Theodore WH
    Epilepsy Res; 1996 Mar; 23(2):129-37. PubMed ID: 8964274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Felbamate in the treatment of refractory partial-onset seizures.
    Jensen PK
    Epilepsia; 1993; 34 Suppl 7():S25-9. PubMed ID: 8243375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic and pharmacokinetic interaction studies of loreclezole with felbamate, lamotrigine, topiramate, and oxcarbazepine in the mouse maximal electroshock seizure model.
    Luszczki JJ; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Epilepsia; 2005 Mar; 46(3):344-55. PubMed ID: 15730531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.